As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teva ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in 2025.

SOPA Images / Contributor / Getty Images Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 treatment for eye disorders.

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...

Teva Pharmaceutical Industries saw its stock price move up 14% over the last week, a notable jump attributed partially to recent regulatory milestones. The U.S. FDA's acceptance of a Supplemental New ...

Aetna recently filed a lawsuit against pharmaceutical manufacturers for allegedly conspiring to overcharge the insurer for ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version of ...

Teva Pharmaceutical Industries Limited (NYSE ... York Stock Exchange and is a member of the Pharmaceutical Research and Manufacturers of America (PhRMA). With a strong global presence spanning ...